Common Stock (Details)							1 Months Ended	3 Months Ended		9 Months Ended
	Jun. 21, 2016 USD ($) shares	May 17, 2016 USD ($) shares	Apr. 22, 2016 USD ($) shares	Apr. 29, 2015 $ / shares shares	Mar. 01, 2015 USD ($) shares	Jan. 02, 2015 USD ($) Nonexecutivedirectors shares	Feb. 24, 2015 USD ($) Nonexecutivedirectors shares	Sep. 30, 2016 USD ($) shares	Sep. 30, 2015 USD ($) shares	Sep. 30, 2016 USD ($) shares	Sep. 30, 2015 USD ($) shares	Apr. 28, 2016 shares	Mar. 17, 2016 shares	Feb. 09, 2015 shares	Jan. 08, 2015 shares
Subsidiary, Sale of Stock [Line Items]
Warrant purchased aggregate price | $											$ 1,845,892
Restricted shares issued					400,000
Restricted shares issued value | $					$ 104,000
Warrants outstanding to purchase				55,334,490
Class of warrant or right outstanding associated with anti-dilutive provision (in shares)				38,888,147
Reduced exercise price (in dollars per share) | $ / shares				$ 0.00005
Percentage of warrants receive common stock in exchange				17.50%
Extension term of warrants to waive anti-dilution rights				2 years
Loss on exchange of warrants | $											$ (12,959,654)
Kahn Employment Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Shares granted		6,067,931
Share-based compensation expense | $		$ 180,824
Common Stock diluted basis, description										Mr. Kahn will receive an additional grant of fully-vested common stock, such additional grants each representing 0.75% of the Company's shares of common stock on a fully diluted basis as of May 1, 2017 and May 1, 2018, respectively. The Company expensed $13,879 through Sept 30, 2016 for stock compensation related to the May 1, 2017 and May 1, 2018 additional grants. The Company will expense a portion of this compensation quarterly until the grants are made at their respective due dates.
Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Class of warrant or right outstanding associated with anti-dilutive provision (in shares)															15,512,057
Warrants issued to purchase common stock (in shares)															54,400,204
Common Stock [Member] | Alternative (1) [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants issued to purchase common stock (in shares)								52,110,896	52,110,896	52,110,896	52,110,896
Common Stock [Member] | Alternative (3) [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants issued to purchase common stock (in shares)								974,826	974,826	974,826	974,826
Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Warrant purchased			4,610,179
Warrant purchased aggregate price | $			$ 122,986
Warrants issued to purchase common stock (in shares)								52,897,601		52,897,601
Warrant [Member] | Alternative (2) [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants issued to purchase common stock (in shares)									318,750		318,750
Warrant [Member] | Alternative (3) [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants issued to purchase common stock (in shares)									73,125		73,125
Non-Executive Directors [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued for services (in shares)						285,716	576,924
Share-based compensation expense | $						$ 160,001	$ 150,000
Number of non-executive directors | Nonexecutivedirectors						4	3
Mark Hershorn [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued for services (in shares)						71,429
Brian Israel [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued for services (in shares)						71,429	192,308
Morris Garfinkle [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued for services (in shares)	2,013,423					71,429	192,308
Share-based compensation expense | $	$ 160,001								$ 3,749,259
Warrants issued to purchase common stock (in shares)													400,000	5,500,000
Edward Smith III [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued for services (in shares)						71,429
Dan jeffery [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued for services (in shares)							192,308
Warrants issued to purchase common stock (in shares)												150,000	200,000